INTERCURE LTD (INCR) Stock Income Statement
NASDAQ:INCR - Nasdaq - IL0011063760 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 238.84M | 355.55M | 388.68M | 219.68M | 65.03M | |||
| Minority Interest Expense | 5.00M | 1.57M | 1.07M | -2.60M | -1.19M | |||
| Cost Of Goods | 203.25M | 247.21M | 229.73M | 123.69M | 34.65M | |||
| Gross Profit | 35.59M | 108.34M | 158.96M | 95.99M | 30.39M | |||
| Operating Expenses | 84.88M | 76.64M | 95.55M | 56.49M | 70.38M | |||
| Research and Development | 414.00K | 388.00K | 632.00K | 1.24M | 1.58M | |||
| Selling, General, and Administrative Expenses | 101.51M | 90.60M | 97.30M | 47.49M | 26.30M | |||
| Operating Income | -49.29M | 31.70M | 63.41M | 39.50M | -39.99M | |||
| Interest Income/Expense | -30.53M | -21.22M | -15.43M | -15.90M | 356.00K | |||
| Other Income/Expense | -2.15M | -828.00K | -266.00K | -4.63M | -264.00K | |||
| Non Recurring Items | -5.36M | -70.93M | -3.87M | -4.86M | 1.59M | |||
| Income Before Taxes | -87.32M | -61.28M | 43.84M | 18.74M | -38.31M | |||
| Income Tax | -14.53M | 2.25M | 93.00K | 11.44M | -2.27M | |||
| Net Income | -67.80M | -61.96M | 44.82M | 4.69M | -37.23M | |||
| EBITDA | -33.92M | 44.86M | 75.11M | 46.89M | -36.74M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.48 | -1.36 | 0.99 | 0.10 | -1.42 | |||
| Statistics | ||||||||
| Gross Profit Margin | 14.90% | 30.47% | 40.90% | 43.70% | 46.72% | |||
| Profit Margin | -28.38% | -17.43% | 11.53% | 2.14% | -57.25% | |||
| Operating Profit Margin | -20.64% | 8.91% | 16.31% | 17.98% | -61.49% | |||
All data in ILS